Malaria: Difference between revisions
From WikiDemocracy
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 227: | Line 227: | ||
[https://www.malariavaccine.org/existing-vaccines/rtss by PATH] | [https://www.malariavaccine.org/existing-vaccines/rtss by PATH] | ||
On October 6, 2021, the World Health Organization (WHO) recommended RTS,S/AS01, the world’s first malaria vaccine, for use in children at risk of malaria caused by Plasmodium falciparum. The WHO recommendation was informed by available evidence on RTS,S, including findings from a pilot implementation of the vaccine through routine childhood immunization in areas of Ghana, Kenya, and Malawi. | On October 6, 2021, the World Health Organization (WHO) recommended RTS,S/AS01, the world’s first malaria vaccine, for use in children at risk of malaria caused by Plasmodium falciparum. The WHO recommendation was informed by available evidence on RTS,S, including findings from a pilot implementation of the vaccine through routine childhood immunization in areas of Ghana, Kenya, and Malawi. | ||
=====Malaria Vaccine Research & Development Plan===== | |||
[https://sanaria.com/research-development/ by SANARIA] | |||
Sanaria’s innovative vaccines based on live attenuated sporozoites have shown excellent efficacy in trials in the United States, Germany, and multiple countries in Africa. | |||
